EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

POPDx: an automated framework for patient phenotyping across 392 246 individuals in the UK Biobank study

Lu Yang, Sheng Wang, Russ B Altman

Journal of the American Medical Informatics Association · 2023

DOI: 10.1093/jamia/ocac226 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Medical Informatics Association, 2023. Verfasst von Lu Yang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioengineering, Stanford University, Stanford, CA, USA. Hauptthemen laut MEDLINE: Biological Specimen Banks, Machine Learning, Rare Diseases. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Medical Research Council, NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

For the UK Biobank, standardized phenotype codes are associated with patients who have been hospitalized but are missing for many patients who have been treated exclusively in an outpatient setting. We describe a method for phenotype recognition that imputes phenotype codes for all UK Biobank participants. Materials and Methods POPDx (Population-based Objective Phenotyping by Deep Extrapolation) is a bilinear machine learning framework for simultaneously estimating the probabilities of 1538 phenotype codes. We extracted phenotypic and health-related information of 392 246 individuals from the UK Biobank for POPDx development and evaluation. A total of 12 803 ICD-10 diagnosis codes of the patients were converted to 1538 phecodes as gold standard labels. The POPDx framework was evaluated and compared to other available methods on automated multiphenotype recognition.

Results

POPDx can predict phenotypes that are rare or even unobserved in training. We demonstrate substantial improvement of automated multiphenotype recognition across 22 disease categories, and its application in identifying key epidemiological features associated with each phenotype.

Conclusions

POPDx helps provide well-defined cohorts for downstream studies. It is a general-purpose method that can be applied to other biobanks with diverse but incomplete data.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biological Specimen BanksMachine LearningRare DiseasesPhenotypeUnited Kingdom

Stichwörter der Autor:innen

AI in healthcareUK Biobankdeep learningmachine learningpatient phenotypingrare disease

Autor:innen und Institutionen

  • Department of Bioengineering, Stanford University, Stanford, CA, USA.
  • Paul G. Allen School of Computer Science and Engineering, University of Washington, Seattle, WA, USA.
  • Department of Genetics, Stanford University, Stanford, CA, USA.
  • Department of Medicine, Stanford University, Stanford, CA, USA.

Förderung

  • Medical Research Council
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Yang, L., Wang, S., & Altman, R. B. (2023). POPDx: an automated framework for patient phenotyping across 392 246 individuals in the UK Biobank study. Journal of the American Medical Informatics Association. https://doi.org/10.1093/jamia/ocac226

Vancouver

Yang L, Wang S, Altman RB. POPDx: an automated framework for patient phenotyping across 392 246 individuals in the UK Biobank study. Journal of the American Medical Informatics Association. 2023. doi:10.1093/jamia/ocac226

BibTeX
@article{Yang2023,
  author = {Yang, Lu and Wang, Sheng and Altman, Russ B},
  title = {POPDx: an automated framework for patient phenotyping across 392 246 individuals in the UK Biobank study},
  journal = {Journal of the American Medical Informatics Association},
  year = {2023},
  doi = {10.1093/jamia/ocac226}
}
Kostenlos starten →